PDB Short entry for 2UWQ HEADER APOPTOSIS 22-MAR-07 2UWQ TITLE SOLUTION STRUCTURE OF ASPP2 N-TERMINUS COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOPTOSIS-STIMULATING OF P53 PROTEIN 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 1-83; COMPND 5 SYNONYM: TUMOR SUPPRESSOR P53-BINDING PROTEIN 2,P53-BINDING PROTEIN COMPND 6 2,P53BP2,53BP2, BCL2-BINDING PROTEIN, BBP, RENAL CARCINOMA ANTIGEN COMPND 7 NY-REN-51; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PRSET KEYWDS ASPP2, UBIQUITIN-LIKE, SH3-DOMAIN, APOPTOSIS, CELL CYCLE, ANK REPEAT, KEYWDS 2 SH3-BINDING EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR H.TIDOW,T.J.RUTHERFORD,A.ANDREEVA,A.R.FERSHT REVDAT 3 09-MAY-18 2UWQ 1 JRNL REMARK REVDAT 2 24-FEB-09 2UWQ 1 VERSN REVDAT 1 10-JUL-07 2UWQ 0 JRNL AUTH H.TIDOW,A.ANDREEVA,T.J.RUTHERFORD,A.R.FERSHT JRNL TITL SOLUTION STRUCTURE OF ASPP2 N-TERMINAL DOMAIN (N-ASPP2) JRNL TITL 2 REVEALS A UBIQUITIN-LIKE FOLD. JRNL REF J. MOL. BIOL. V. 371 948 2007 JRNL REFN ISSN 0022-2836 JRNL PMID 17594908 JRNL DOI 10.1016/J.JMB.2007.05.024 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS, GROSSE- REMARK 3 KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU,READ, RICE, REMARK 3 SIMONSON,WARREN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2UWQ COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-MAR-07. REMARK 100 THE DEPOSITION ID IS D_1290029905. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298.0; 298.0 REMARK 210 PH : 7.2; 7.2 REMARK 210 IONIC STRENGTH : 213; 213 REMARK 210 PRESSURE : 1.0 ATM; 1.0 ATM REMARK 210 SAMPLE CONTENTS : 25MM PHOSPHATE, PH7.2, 150MM REMARK 210 NACL, 5MM DTT, 5%D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : COSY; TOCSY; HNCO; HNCACO; REMARK 210 CBCACONH; HNCACB; CCCONH; NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : DRX; AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CNS REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 90 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : LOWEST ENERGY, NO VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 19 REMARK 210 REMARK 210 REMARK: THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR REMARK 210 SPECTROSCOPY. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 3 -172.01 -57.10 REMARK 500 1 SER A 11 149.08 82.80 REMARK 500 1 ASN A 12 83.82 -60.34 REMARK 500 1 ASN A 13 141.71 -179.12 REMARK 500 1 GLU A 25 -51.15 -137.28 REMARK 500 1 CYS A 28 23.28 38.07 REMARK 500 1 CYS A 35 32.90 -99.50 REMARK 500 1 GLU A 37 -62.64 177.24 REMARK 500 1 GLU A 40 96.73 -60.00 REMARK 500 1 MET A 62 -79.48 -31.37 REMARK 500 1 ASN A 74 36.05 -98.82 REMARK 500 2 MET A 1 -82.60 -66.34 REMARK 500 2 MET A 2 -60.85 -124.53 REMARK 500 2 PRO A 3 150.79 -47.19 REMARK 500 2 SER A 11 -162.85 60.21 REMARK 500 2 ASN A 12 37.86 -94.11 REMARK 500 2 CYS A 28 22.82 37.47 REMARK 500 2 CYS A 35 32.26 -96.60 REMARK 500 2 GLU A 37 -63.52 -173.02 REMARK 500 2 ASP A 42 77.28 71.56 REMARK 500 2 MET A 62 -76.98 -27.25 REMARK 500 2 SER A 71 -42.00 -138.09 REMARK 500 2 GLN A 72 90.46 -65.92 REMARK 500 3 MET A 1 164.00 60.59 REMARK 500 3 PRO A 3 -177.09 -51.78 REMARK 500 3 SER A 11 -177.20 58.10 REMARK 500 3 PRO A 24 58.61 -69.89 REMARK 500 3 GLU A 25 -45.93 -130.94 REMARK 500 3 CYS A 28 23.25 37.66 REMARK 500 3 PRO A 38 90.02 -51.48 REMARK 500 3 ASP A 42 94.80 61.78 REMARK 500 3 MET A 62 -81.57 -22.57 REMARK 500 3 ASN A 74 32.91 -97.02 REMARK 500 4 PRO A 3 -179.03 -69.47 REMARK 500 4 SER A 11 -104.30 38.38 REMARK 500 4 GLU A 14 -55.45 -175.25 REMARK 500 4 GLU A 25 -54.46 -142.36 REMARK 500 4 CYS A 28 23.20 38.25 REMARK 500 4 PRO A 38 104.28 -51.87 REMARK 500 4 ASP A 42 93.06 60.12 REMARK 500 4 MET A 62 -83.62 -33.05 REMARK 500 4 SER A 71 -38.49 -179.12 REMARK 500 4 GLN A 72 88.14 -69.17 REMARK 500 5 SER A 11 -164.49 59.41 REMARK 500 5 ASN A 12 36.50 -95.92 REMARK 500 5 GLU A 25 -48.33 -143.95 REMARK 500 5 CYS A 28 22.97 38.06 REMARK 500 5 PRO A 38 85.04 -58.59 REMARK 500 5 ASP A 42 99.96 61.00 REMARK 500 5 MET A 62 -79.58 -33.49 REMARK 500 REMARK 500 THIS ENTRY HAS 198 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1YCS RELATED DB: PDB REMARK 900 P53-53BP2 COMPLEX REMARK 999 REMARK 999 SEQUENCE REMARK 999 N-TERMINAL GGS DUE TO CLEAVAGE FROM FUSION PROTEIN DBREF 2UWQ A -2 0 PDB 2UWQ 2UWQ -2 0 DBREF 2UWQ A 1 83 UNP Q13625 ASPP2_HUMAN 1 83 SEQRES 1 A 86 GLY GLY SER MET MET PRO MET PHE LEU THR VAL TYR LEU SEQRES 2 A 86 SER ASN ASN GLU GLN HIS PHE THR GLU VAL PRO VAL THR SEQRES 3 A 86 PRO GLU THR ILE CYS ARG ASP VAL VAL ASP LEU CYS LYS SEQRES 4 A 86 GLU PRO GLY GLU SER ASP CYS HIS LEU ALA GLU VAL TRP SEQRES 5 A 86 CYS GLY SER GLU ARG PRO VAL ALA ASP ASN GLU ARG MET SEQRES 6 A 86 PHE ASP VAL LEU GLN ARG PHE GLY SER GLN ARG ASN GLU SEQRES 7 A 86 VAL ARG PHE PHE LEU ARG HIS GLU HELIX 1 1 CYS A 28 CYS A 35 1 8 HELIX 2 2 ARG A 61 GLY A 70 1 10 HELIX 3 3 GLN A 72 VAL A 76 5 5 SHEET 1 AA 5 PHE A 17 VAL A 22 0 SHEET 2 AA 5 MET A 4 TYR A 9 -1 O MET A 4 N VAL A 22 SHEET 3 AA 5 ARG A 77 ARG A 81 1 O PHE A 78 N TYR A 9 SHEET 4 AA 5 HIS A 44 TRP A 49 -1 O HIS A 44 N ARG A 81 SHEET 5 AA 5 SER A 52 VAL A 56 -1 O SER A 52 N TRP A 49 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000